As of 2026-01-28, the Intrinsic Value of Medicenna Therapeutics Corp (MDNA.TO) is -0.83 CAD. This MDNA.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.90 CAD, the upside of Medicenna Therapeutics Corp is -192.02%.
Based on its market price of 0.90 CAD and our intrinsic valuation, Medicenna Therapeutics Corp (MDNA.TO) is overvalued by 192.02%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.83 - -0.83 | -0.83 | -192.02% |
| P/E | (0.23) - (0.34) | (0.28) | -131.3% |
| DDM - Stable | (1.36) - (5.07) | (3.22) | -457.3% |
| DDM - Multi | (0.09) - (0.26) | (0.13) | -114.6% |
| Market Cap (mil) | 75.07 |
| Beta | 2.27 |
| Outstanding shares (mil) | 83.41 |
| Enterprise Value (mil) | 59.47 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.74% |
| Cost of Debt | 5.00% |
| WACC | 9.73% |